Exciting News! Saama Wins “AI-based Life Sciences Solution of the Year” Award in 2026 AI Breakthrough Awards
Labs and adverse events (AEs) are two views of the same patient. When medical monitors, safety reviewers, or CRAs assess them through separate workflows —
For 60 years, clinical trial data has moved on a one-way delay: sites collect it, sponsors analyze it, and only then does it reach the
In the high-stakes environment of clinical development, the burden of documentation has reached a tipping point. Medical writers and clinical teams are increasingly sidelined by
If you read Part 1 of this series, you’ve already seen how Interactive Review Listings (IRLs) simplify and speed up the core data review process.
How AI evolved from pattern recognition to autonomous reasoning, and why pharmaceutical leaders need to understand the difference The $2.23 Billion Question Developing a single
Let’s take a minute to think about what it really takes to bring a new medicine to patients- it’s a massive, critical effort, but too
AI’s potential in life sciences isn’t limited by technology- it’s limited by how we communicate with it. The most powerful AI tools can fall short
Clinical trials are under tremendous pressure. Over the past decade, protocols have become more complex, regulatory requirements have tightened, and the cost of bringing a
Traditional data quality checks have served clinical research well for decades, catching obvious issues like missing fields and chronological errors. But as studies grow more
Get our perspectives on AL/ML in the life sciences industry directly to your inbox.
